Bill Hartzel's most recent trade in Emergent Biosolutions Inc was a trade of 1,167 Common Stock done at an average price of $6.6 . Disclosure was reported to the exchange on June 8, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Emergent Biosolutions Inc | Bill Hartzel | SVP, Bioservices | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.63 per share. | 08 Jun 2025 | 1,167 | 107,955 (0%) | 0% | 6.6 | 7,737 | Common Stock |
Emergent Biosolutions Inc | Bill Hartzel | SVP, Bioservices | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.44 per share. | 07 Apr 2025 | 561 | 109,122 (0%) | 0% | 4.4 | 2,491 | Common Stock |
Emergent Biosolutions Inc | Bill Hartzel | SVP, Bioservices | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 62,500 | 109,975 (0%) | 0% | 0 | Common Stock | |
Emergent Biosolutions Inc | Bill Hartzel | SVP, Bioservices | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 62,500 | 214,711 | - | - | Employee Stock Options (Right to Buy) | |
Emergent Biosolutions Inc | Bill Hartzel | SVP, Bioservices | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 62,500 | 109,683 (0%) | 0% | 0 | Common Stock | |
Emergent Biosolutions Inc | Bill Hartzel | SVP, Bioservices | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.80 per share. | 05 Mar 2025 | 292 | 47,183 (0%) | 0% | 5.8 | 1,694 | Common Stock |
Emergent Biosolutions Inc | Bill Hartzel | SVP, Bioservices | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.97 per share. | 11 Nov 2024 | 632 | 47,475 (0%) | 0% | 12.0 | 7,565 | Common Stock |
Emergent Biosolutions Inc | Bill Hartzel | SVP, Bioservices | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2024 | 15,000 | 48,107 (0%) | 0% | 0 | Common Stock | |
Emergent Biosolutions Inc | Bill Hartzel | SVP, Bioservices | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.19 per share. | 08 Jun 2024 | 1,167 | 33,107 (0%) | 0% | 6.2 | 7,224 | Common Stock |
Emergent Biosolutions Inc | Bill Hartzel | SVP, Bioservices | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.29 per share. | 07 Apr 2024 | 665 | 34,274 (0%) | 0% | 2.3 | 1,523 | Common Stock |
Emergent Biosolutions Inc | Bill Hartzel | SVP, Bioservices | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 125,000 | 152,211 | - | - | Employee Stock Options (Right to Buy) | |
Emergent Biosolutions Inc | Bill Hartzel | SVP, Bioservices | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.41 per share. | 05 Mar 2024 | 346 | 34,939 (0%) | 0% | 3.4 | 1,180 | Common Stock |
Emergent Biosolutions Inc | Bill Hartzel | SVP, Bioservices | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.00 per share. | 11 Nov 2023 | 632 | 35,285 (0%) | 0% | 2 | 1,264 | Common Stock |